DiaMedica Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, DiaMedica Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $15.5. The average 1-year stock price forecast is 172.41% higher than the current stock price, while the lowest is $11 (+93.32%) and the highest is $25 (+339.37%).

Price Target: $15.5 (+172.41%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$15.5	$13	$25
Change	+93.32%	+172.41%	+128.47%	+339.37%

* Price targets were last updated on Nov 14, 2025.

Analyst Ratings

The average analyst rating for DiaMedica Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $25	Buy	Initiates	$25	+339.37%	Nov 14, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+110.90%	Aug 15, 2025
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Maintains $8 → $11	Strong Buy	Maintains	$8 → $11	+93.32%	Jul 18, 2025
Thomas Flaten Lake Street	Lake Street	Strong Buy Maintains $11 → $14	Strong Buy	Maintains	$11 → $14	+146.05%	Jul 18, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $12	Strong Buy	Maintains	$10 → $12	+110.90%	Jul 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

2.84M

EPS This Year

-0.79

from -0.70

EPS Next Year

-0.85

from -0.79

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	2.84M
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.65	-0.52	-0.60	-0.60	-0.70	-0.79	-0.85
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	11.7M
Avg	n/a	2.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.63	-0.61
Avg	-0.79	-0.85
Low	-0.88	-0.98

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.